Registro:

Referencias:

• Aaronson, D.S., Horvath, C.M., A road map for those who don't know JAK-STAT (2002) Science, 296, pp. 1653-1655
• Amin, H.M., McDonnell, T.J., Ma, Y., Lin, Q., Fujio, Y., Kunisada, K., Leventaki, V., Lai, R., Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma (2004) Oncogene, 23, pp. 5426-5434
• Balana, M.E., Labriola, L., Salatino, M., Movsichoff, F., Peters, G., Charreau, E.H., Elizalde, P.V., Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells (2001) Oncogene, 20, pp. 34-47
• Balana, M.E., Lupu, R., Labriola, L., Charreau, E.H., Elizalde, P.V., Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas (1999) Oncogene, 18, pp. 6370-6379
• Ballare, C., Uhrig, M., Bechtold, T., Sancho, E., Di Domenico, M., Migliaccio, A., Auricchio, F., Beato, M., Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells (2003) Mol. Cell. Biol., 23, pp. 1994-2008
• Boonyaratanakornkit, V., Scott, M.P., Ribon, V., Sherman, L., Anderson, S.M., Maller, J.L., Miller, W.T., Edwards, D.P., Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases (2001) Mol. Cell, 8, pp. 269-280
• Bowman, T., Garcia, R., Turkson, J., Jove, R., STATs in oncogenesis (2000) Oncogene, 19, pp. 2474-2488
• Braunsberg, H., Coldham, N.G., Leake, R.E., Cowan, S.K., Wong, W., Actions of a progestogen on human breast cancer cells: Mechanisms of growth stimulation and inhibition (1987) Eur. J. Cancer Clin. Oncol., 23, pp. 563-571
• Bromberg, J., Darnell Jr., J.E., The role of STATs in transcriptional control and their impact on cellular function (2000) Oncogene, 19, pp. 2468-2473
• Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W., Darnell Jr., J.E., Stat3 activation is required for cellular transformation by v-src (1998) Mol. Cell. Biol., 18, pp. 2553-2558
• Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., Darnell Jr., J.E., Stat3 as an oncogene (1999) Cell, 98, pp. 295-303
• Burke, W.M., Jin, X., Lin, H.J., Huang, M., Liu, R., Reynolds, R.K., Lin, J., Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells (2001) Oncogene, 20, pp. 7925-7934
• Castoria, G., Barone, M.V., Di Domenico, M., Bilancio, A., Ametrano, D., Migliaccio, A., Auricchio, F., Non-transcriptional action of oestradiol and progestin triggers DNA synthesis (1999) EMBO J., 18, pp. 2500-2510
• Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Jove, R., Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells (1999) Immunity, 10, pp. 105-115
• Clarke, C.L., Sutherland, R.L., Progestin regulation of cellular proliferation (1990) Endocr. Rev., 11, pp. 266-301
• Darnell Jr., J.E., Kerr, I.M., Stark, G.R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins (1994) Science, 264, pp. 1415-1421
• Dechow, T.N., Pedranzini, L., Leitch, A., Leslie, K., Gerald, W.L., Linkov, I., Bromberg, J.F., Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C (2004) Proc. Natl. Acad. Sci. USA, 101, pp. 10602-10607
• De Miguel, F., Lee, S.O., Onate, S.A., Gao, A.C., Stat3 enhances transactivation of steroid hormone receptors (2003) Nucl. Recept., 1, p. 3
• Dran, G., Luthy, I.A., Molinolo, A.A., Montecchia, F., Charreau, E.H., Pasqualini, C.D., Lanari, C., Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma (1995) Breast Cancer Res. Treat., 35, pp. 173-186
• Garcia, R., Bowman, T.L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C.A., Cox, C.E., Jove, R., Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells (2001) Oncogene, 20, pp. 2499-2513
• Groshong, S.D., Owen, G.I., Grimison, B., Schauer, I.E., Todd, M.C., Langan, T.A., Sclafani, R.A., Horwitz, K.B., Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1) (1997) Mol. Endocrinol., 11, pp. 1593-1607
• Jing, N., Li, Y., Xiong, W., Sha, W., Jing, L., Tweardy, D.J., G-quartet oligonucleotides: A new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis (2004) Cancer Res., 64, pp. 6603-6609
• Kaptein, A., Paillard, V., Saunders, M., Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction (1996) J. Biol. Chem., 271, pp. 5961-5964
• Kiss, R., Paridaens, R.J., Heuson, J.C., Danguy, A.J., Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm (1986) J. Natl. Cancer Inst., 77, pp. 173-178
• Labriola, L., Salatino, M., Proietti, C.J., Pecci, A., Coso, O.A., Kornblihtt, A.R., Charreau, E.H., Elizalde, P.V., Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells (2003) Mol. Cell. Biol., 23, pp. 1095-1111
• Lange, C.A., Richer, J.K., Shen, T., Horwitz, K.B., Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways (1998) J. Biol. Chem., 273, pp. 31308-31316
• Leonhardt, S.A., Boonyaratanakornkit, V., Edwards, D.P., Progesterone receptor transcription and non-transcription signaling mechanisms (2003) Steroids, 68, pp. 761-770
• Li, L., Shaw, P.E., Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines (2002) J. Biol. Chem., 277, pp. 17397-17405
• Lin, V.C., Jin, R., Tan, P.H., Aw, S.E., Woon, C.T., Bay, B.H., Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA (2003) Am. J. Pathol., 162, pp. 1781-1787
• Liu, T., Ogle, T.F., Signal transducer and activator of transcription 3 is expressed in the decidualized mesometrium of pregnancy and associates with the progesterone receptor through protein-protein interactions (2002) Biol. Reprod., 67, pp. 114-118
• Lydon, J.P., Sivaraman, L., Conneely, O.M., A reappraisal of progesterone action in the mammary gland (2000) J. Mammary Gland Biol. Neoplasia, 5, pp. 325-338
• Manni, A., Badger, B., Wright, C., Ahmed, S.R., Demers, L.M., Effects of progestins on growth of experimental breast cancer in culture: Interaction with estradiol and prolactin and involvement of the polyamine pathway (1987) Cancer Res., 47, pp. 3066-3071
• Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Auricchio, F., Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor (1998) EMBO J., 17, pp. 2008-2018
• Moore, M.R., Conover, J.L., Franks, K.M., Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells (2000) Biochem. Biophys. Res. Commun., 277, pp. 650-654
• Niu, G., Heller, R., Catlett-Falcone, R., Coppola, D., Jaroszeski, M., Dalton, W., Jove, R., Yu, H., Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo (1999) Cancer Res., 59, pp. 5059-5063
• Niu, G., Shain, K.H., Huang, M., Ravi, R., Bedi, A., Dalton, W.S., Jove, R., Yu, H., Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest (2001) Cancer Res., 61, pp. 3276-3280
• Niu, G., Wright, K.L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Yu, H., Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis (2002) Oncogene, 21, pp. 2000-2008
• Olayioye, M.A., Beuvink, I., Horsch, K., Daly, J.M., Hynes, N.E., ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases (1999) J. Biol. Chem., 274, pp. 17209-17218
• Paukku, K., Valgeirsdottir, S., Saharinen, P., Bergman, M., Heldin, C.H., Silvennoinen, O., Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases (2000) Biochem. J., 345 (PART 3), pp. 759-766
• Puricelli, L., Proiettii, C.J., Labriola, L., Salatino, M., Balana, M.E., Aguirre, G.J., Lupu, R., Elizalde, P.V., Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (2002) Int. J. Cancer, 100, pp. 642-653
• Real, P.J., Sierra, A., De Juan, A., Segovia, J.C., Lopez-Vega, J.M., Fernandez-Luna, J.L., Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells (2002) Oncogene, 21, pp. 7611-7618
• Ren, Z., Schaefer, T.S., ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner (2002) J. Biol. Chem., 277, pp. 38486-38493
• Richer, J.K., Lange, C.A., Manning, N.G., Owen, G., Powell, R., Horwitz, K.B., Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity (1998) J. Biol. Chem., 273, pp. 31317-31326
• Salatino, M., Schillaci, R., Proietti, C.J., Carnevale, R., Frahm, I., Molinolo, A.A., Iribarren, A., Elizalde, P.V., Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity (2004) Oncogene, 23, pp. 5161-5174
• Sartor, C.I., Dziubinski, M.L., Yu, C.L., Jove, R., Ethier, S.P., Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells (1997) Cancer Res., 57, pp. 978-987
• Schaefer, L.K., Wang, S., Schaefer, T.S., Oncostatin M activates stat DNA binding and transcriptional activity in primary human fetal astrocytes: Low- and high-passage cells have distinct patterns of stat activation (2000) Cytokine, 12, pp. 1647-1655
• Schulze, H., Ballmaier, M., Welte, K., Germeshausen, M., Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets (2000) Exp. Hematol., 28, pp. 294-304
• Shen, T., Horwitz, K.B., Lange, C.A., Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent downregulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294 (2001) Mol. Cell. Biol., 21, pp. 6122-6131
• Sherman, C.T., Brasier, A.R., Role of signal transducers and activators of transcription 1 and 3 in inducible regulation of the human angiotensinogen gene by interleukin-6 (2001) Mol. Endocrinol., 15, pp. 441-457
• Silvennoinen, O., Schindler, C., Schlessinger, J., Levy, D.E., Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation (1993) Science, 261, pp. 1736-1739
• Stoecklin, E., Wissler, M., Schaetzle, D., Pfitzner, E., Groner, B., Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family (1999) J. Steroid Biochem. Mol. Biol., 69, pp. 195-204
• Taga, T., Kishimoto, T., Gp130 and the interleukin-6 family of cytokines (1997) Annu. Rev. Immunol., 15, pp. 797-819
• Vultur, A., Cao, J., Arulanandam, R., Turkson, J., Jove, R., Greer, P., Craig, A., Raptis, L., Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells (2004) Oncogene, 23, pp. 2600-2616
• Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Yu, H., Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells (2004) Nat. Med., 10, pp. 48-54
• Yu, H., Jove, R., The STATs of cancer-new molecular targets come of age (2004) Nat. Rev. Cancer, 4, pp. 97-105
• Zhang, X., Wrzeszczynska, M.H., Horvath, C.M., Darnell Jr., J.E., Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation (1999) Mol. Cell. Biol., 19, pp. 7138-7146
• Zhang, Y., Turkson, J., Carter-Su, C., Smithgall, T., Levitzki, A., Kraker, A., Krolewski, J.J., Jove, R., Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity (2000) J. Biol. Chem., 275, pp. 24935-24944
• Zhang, Z., Jones, S., Hagood, J.S., Fuentes, N.L., Fuller, G.M., STAT3 acts as a co-activator of glucocorticoid receptor signaling (1997) J. Biol. Chem., 272, pp. 30607-30610
• Zhu, Y., Bond, J., Thomas, P., Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 2237-2242

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------